loadpatents
name:-0.044996023178101
name:-0.014647960662842
name:-0.013098001480103
Hironiwa; Naoka Patent Filings

Hironiwa; Naoka

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hironiwa; Naoka.The latest application filed is for "antigen-binding molecule containing modified fc region".

Company Profile
9.9.36
  • Hironiwa; Naoka - Shizuoka JP
  • Hironiwa; Naoka - Synapse SG
  • Hironiwa; Naoka - Singapore SG
  • HIRONIWA; Naoka - .Singapore SG
  • HIRONIWA; Naoka - Gotemba-shi JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antigen-binding Molecule Containing Modified Fc Region
App 20220242934 - Igawa; Tomoyuki ;   et al.
2022-08-04
Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusion
Grant 11,400,157 - Igawa , et al. August 2, 2
2022-08-02
Ion Concentration-dependent Binding Molecule Library
App 20220187308 - IGAWA; Tomoyuki ;   et al.
2022-06-16
Anti-il-31ra Antibody-containing Formulations
App 20220184210 - Kameoka; Daisuke ;   et al.
2022-06-16
Antibody-containing Formulations
App 20220125921 - Kameoka; Daisuke ;   et al.
2022-04-28
Antigen-binding Domain, And Polypeptide Including Conveying Section
App 20220073632 - IGAWA; Tomoyuki ;   et al.
2022-03-10
Anti-IL31RA antibody-containing formulations
Grant 11,260,125 - Kameoka , et al. March 1, 2
2022-03-01
Library Of Antigen-binding Molecules Including Modified Antibody Variable Region
App 20220040297 - Igawa; Tomoyuki ;   et al.
2022-02-10
Ion concentration-dependent binding molecule library
Grant 11,243,210 - Igawa , et al. February 8, 2
2022-02-08
Antigen-binding domain, and polypeptide including conveying section
Grant 11,168,139 - Igawa , et al. November 9, 2
2021-11-09
Library of antigen-binding molecules including modified antibody variable region
Grant 11,154,615 - Igawa , et al. October 26, 2
2021-10-26
Anti-cd137 Antigen-binding Molecule And Utilization Thereof
App 20210324099 - IGAWA; Tomoyuki ;   et al.
2021-10-21
Antibody-containing Formulations
App 20210322550 - Kameoka; Daisuke ;   et al.
2021-10-21
Antigen-binding molecule containing modified Fc region
Grant 11,142,563 - Igawa , et al. October 12, 2
2021-10-12
Ligand-binding Molecule Containing Single Domain Antibody
App 20210253672 - ISHIKAWA; Hiroyuki ;   et al.
2021-08-19
Antigen-binding Molecule Showing Changed Half-life In Cytoplasm
App 20210238308 - IKAWA; Yuri ;   et al.
2021-08-05
Cytotoxicity-inducing Therapeutic Agent
App 20210230311 - NEZU; Junichi ;   et al.
2021-07-29
Polypeptide Comprising Aggrecan Binding Domain And Carrying Moiety
App 20210221875 - KITAMURA; Hidetomo ;   et al.
2021-07-22
Polypeptide Comprising Il-1r1 Binding Domain And Carrying Moiety
App 20210155701 - HOSHINO; Maiko ;   et al.
2021-05-27
Cytotoxicity-inducing therapeutic agent
Grant 11,001,643 - Nezu , et al. May 11, 2
2021-05-11
Antigen-binding Molecule For Eliminating Aggregated Antigens
App 20210122812 - Igawa; Tomoyuki ;   et al.
2021-04-29
Antigen-binding Molecule And Combination
App 20200399373 - IGAWA; Tomoyuki ;   et al.
2020-12-24
Antigen-binding Molecule Comprising Altered Antibody Variable Region Binding Cd3 And Cd137
App 20200377595 - Shimizu; Shun ;   et al.
2020-12-03
Polypeptide Including Antigen-binding Domain And Carrying Section
App 20200369781 - IGAWA; Tomoyuki ;   et al.
2020-11-26
Antigen-binding Molecule Containing Modified Antibody Variable Region
App 20200332001 - Igawa; Tomoyuki ;   et al.
2020-10-22
Antigen-binding Molecule Having Regulated Conjugation Between Heavy-chain And Light-chain
App 20200087380 - Kuramochi; Taichi ;   et al.
2020-03-19
Antigen-binding Domain, And Polypeptide Including Conveying Section
App 20190359721 - IGAWA; Tomoyuki ;   et al.
2019-11-28
Drug Containing Carrier Into Cell For Forming Immune Complex
App 20190218309 - Igawa; Tomoyuki ;   et al.
2019-07-18
Ion Concentration-dependent Binding Molecule Library
App 20190041396 - IGAWA; Tomoyuki ;   et al.
2019-02-07
Library Of Antigen-binding Molecules Including Modified Antibody Variable Region
App 20180296668 - Igawa; Tomoyuki ;   et al.
2018-10-18
Antigen-binding Molecule Capable Of Binding To Plurality Of Antigen Molecules Repeatedly
App 20180258161 - Igawa; Tomoyuki ;   et al.
2018-09-13
Cytotoxicity-inducing Therapeutic Agent
App 20180244805 - NEZU; Junichi ;   et al.
2018-08-30
Ion concentration-dependent binding molecule library
Grant 10,024,867 - Igawa , et al. July 17, 2
2018-07-17
Cytotoxicity-inducing theraputic agent
Grant 9,975,966 - Nezu , et al. May 22, 2
2018-05-22
Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion
App 20180125972 - IGAWA; Tomoyuki ;   et al.
2018-05-10
Cytotoxicity-Inducing Therapeutic Agent
App 20170267783 - NEZU; Junichi ;   et al.
2017-09-21
Immunoactivating Antigen-Binding Molecule
App 20170022287 - IGAWA; Tomoyuki ;   et al.
2017-01-26
Antigen-binding Molecule Containing Modified Antibody Variable Region
App 20160280787 - Igawa; Tomoyuki ;   et al.
2016-09-29
Antigen-binding Molecule For Eliminating Aggregated Antigens
App 20150353630 - Igawa; Tomoyuki ;   et al.
2015-12-10
Antigen-binding Molecule Containing Modified Fc Region
App 20150166636 - Igawa; Tomoyuki ;   et al.
2015-06-18
Drug Containing Carrier Into Cell For Forming Immune Complex
App 20150056182 - Igawa; Tomoyuki ;   et al.
2015-02-26
Antigen-binding Molecule Having Regulated Conjugation Between Heavy-chain And Light-chain
App 20140370020 - Kuramochi; Taichi ;   et al.
2014-12-18
Ion Concentration-dependent Binding Molecule Library
App 20140271617 - Igawa; Tomoyuki ;   et al.
2014-09-18
Antigen-binding Molecule Capable Of Binding To Plurality Of Antigen Molecules Repeatedly
App 20140234340 - Igawa; Tomoyuki ;   et al.
2014-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed